🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📣TADS is recruiting! Perfect for early and mid career researchers, join our new Editorial Reviewer Board to make an impact in the Drug Safety field. 🔸Read more: journals.sagepub.com/editorial-revi… 🔸Apply here: surveymonkey.com/r/TAW #DrugSafety #PeerReview #OpenAccess

Tea Babić from Teva Pharmaceuticals talks about her work surrounding #DrugInspections and their processes, while also touching on notable inspection trends from all around the globe. #EUPV2023 #EUPV #Pharmacovigilance #DrugSafety

New research in TADS 💡 Roth et al. analyzed 521 #quetiapine prescriptions and found that 67% of them were inappropriate for the patient, leading to excess costs and compromised #PatientSafety. Learn more below: bit.ly/3tbIH6W #Pharmacovigilance #DrugSafety

Now open for submissions! An exciting new special collection on #ArtificialIntelligence and #MachineLearning in #pharmacovigilance with Andrew Bate and Phil Tregunno as Guest Editors. For more information, please visit the link below: journals.sagepub.com/page/taw/routi…

Exciting news!📢 Discover our first PLS-P (plain language summary of publication) detailing findings from a clinical study on a new #asthma rescue inhaler containing both albuterol and budesonide in a single inhaler🫁 Read more here: journals.sagepub.com/doi/10.1177/17… #OpenAccess

#Anticholinergics #Hospitalisation #Ethiopia #LMICs Kenneth Lee Biniam Seyoum Aberdeen Geriatrics UWA School of Allied Health QUMPRC UoA Medicine, Medical Sciences and Nutrition ousmy Therapeutic Advances in Drug Safety

The Managing Editor of TADS is at #EUPV2024 in Milano! Stop by our table and say hello 👋 #pharmacovigilance #DrugSafety #PatientSafety #pharmacology #OpenAccess

#EUPV2024 has kicked off with strong morning sessions focusing on an industry perspective on evolving #pharmacovigilance strategies. Interesting takes on aspirational #AI use in PV, such as #ClinicalTrial optimisation/simulation and processing individual case safety reports.

An insightful and thought-provoking session of a range of talks about both global and local #pharmacovigilance updates, including updates on good clinical practice and how AI is informing regulatory intelligence. #EUPV2024 #pharmacovigilance #DrugSafety

Summary of the paper published at the Therapeutic Advances in Drug Safety Sage Journals ⬇️

Congratulations to Fatema Alqenae for being awarded best article published in TADS in 2023 during #EUPV2024! Very well-deserved for her article the nature and contributory factors of #MedicationSafety incidents following hospital discharge. Read more here: journals.sagepub.com/doi/10.1177/20…

The third session on practical implementations of #ArtificialInteligence provided us with insights from both academic and industry perspectives. #pharmacovigilance #PatientSafety #DrugSafety #EUPV2024